Press Releases

Events

Publications

Newsletters

Publications

Heschi Rotmensch, MD, MBA

• Heschi Rotmensch. Israel - A Solid Track Record in Clinical Research . JCS Magazine, 9th March 2009.

Amber Barnes, Ph.D.

• Barnes AP, Miller BE, Kucera GL. Cyclooxygenase inhibition and hyperthermia for the potentiation of the cytotoxic response in ovarian cancer cells. Gynecol Oncol 2007;104:443-50.

Omar Ali, Ph.D

• Ali SO, Peynircioglu ZF. Songs and emotions: are lyrics and melodies equal partners? Psychology of Music 2006;34:511-534.

Amber Barnes, Ph.D.

• Barnes AP, Miller BE, Kucera GL. Cyclooxygenase inhibition and hyperthermia for the potentiation of the cytotoxic response in ovarian cancer cells. Gynecol Oncol 2007;104:443-50.

David Bernstein, Ph.D.

• Bernstein D. The integration of CMC into drug development: avoiding the common delays. In: Linberg, SE, ed. Expediting drug and biologics development: a strategic approach. Watham, Ma.: PAREXEL International, 2006:17-23.
  

Kris Callis, M.S.

• Callis K. History of Plant Use in Laos. Selected Papers. First International Conference on Lao Studies. 2006.

Stephanie Cowey, Ph.D.

• Cowey S, Szafran AA, Kappes J, Zinn KR, Siegal GP, Desmond RA, Kim H, Evans L, Hardy RW. Breast cancer metastasis to bone: evaluation of bioluminescent imaging and microSPECT/CT for detecting bone metastasis in immunodeficient mice. Clin Exp Metastasis 2007;24:389-401

Arnavaz Eduljee, M.D.

• Ajani JA, Randolph Hecht J, Ho L, Baker J, Oortgiesen M, Eduljee A, Michaeli D. An open-label, multinational, multicenter study of G17DT vaccination combined with cisplatin and 5-fluorouracil in patients with untreated, advanced gastric or gastroesophageal cancer: the GC4 study. Cancer 2006;106:1908-16.

Joel Eisner, Ph.D.

• Bruns CM, Baum ST, Colman RJ, Dumesic DA, Eisner JR, Jensen MD, Whigham LD, Abbott DH. Prenatal androgen excess negatively impacts body fat distribution in a nonhuman primate model of polycystic ovary syndrome. Int J Obes (Lond) 2007 May 1; [Epub ahead of print]

Kaisheng Fan, Ph.D.

• Ghali JK, Koren MJ, Taylor JR, Brooks-Asplund E, Fan K, Long WA, Smith N. Efficacy and safety of oral conivaptan: a V1A/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia. J Clin Endocrinol Metab 2006;91:2145-2152

Ann Field, Ph.D.

• Conrad SM, Strauss-Ayali D, Field AE, Mack M, Mosser DM. Leishmania-derived murine monocyte chemoattractant protein 1 enhances the recruitment of a restrictive population of CC chemokine receptor 2-positiv macrophages. Infect Immun 2007;75:653-65.
  
• Field AE, Wagage S, Conrad SM, Mosser DM. Reduced pathology following infection with transgenic Leishmania major expressing murine CD40 ligand. Infect Immun 2007;75:3140-9.

Diana Fordyce, Ph.D.

• Fordyce D, Pavliv L. Format and content of the Common Technical Document (CTD). In: Linberg, SE, ed. Expediting drug and biologics development: a strategic approach. Watham, Ma.: PAREXEL International, 2006:67-92.

• Fordyce D, Truocchio SP, Whitney K. Assembling and filing the Common Technical Document. In: Linberg, SE, ed. Expediting drug and biologics development: a strategic approach. Watham, Ma.: PAREXEL International, 2006:289-297.

Greg Fralish, Ph.D.

• Marion S, Fralish GB, Laporte S, Caron MG, Barak LS. N-terminal tyrosine modulation of the endocytic adaptor function of the beta-arrestins. J Biol Chem 2007;282:18937-44

Brandi Whitley Hilder , Ph.D.

• Whitley BR, Beaulieu LM, Carter JC, Church FC. Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells. Gynecol Oncol 2007;104:470-9.

Minerva Hughes, Ph.D.

• Hughes MA, Silva JC, Geromanos SJ, Townsend CA. Quantitative proteomic analysis of drug-induced changes in mycobacteria. J Proteome Res 2006;5:54-63.

William Lee, Ph.D.

• "Regulatory Overview of Conducting Gene Therapy Clinical Trials in the United States," BioProcessing Journal, Vol 5, No 2, Summer 2006.

Arlene Lund, B.Sc., C.C.R.A.

• "Hand Picked For Success: The Site Selection and Evaluation Process," SOCRA Source, Issue 49, August 2006.

Marga Oortgiesen, Ph.D.

• Ajani JA, Randolph Hecht J, Ho L, Baker J, Oortgiesen M, Eduljee A, Michaeli D. An open-label, multinational, multicenter study of G17DT vaccination combined with cisplatin and 5-fluorouracil in patients with untreated, advanced gastric or gastroesophageal cancer: the GC4 study. Cancer 2006;106:1908-16.

• Veronesi B, Oortgiesen M. The TRPV1 receptor: target of toxicants and therapeutics. Toxicol Sci 2006;89:1-3.

Leo Pavliv, M.B.A., R.Ph.,R.A.C.

• Fordyce D, Pavliv L. Format and content of the Common Technical Document (CTD). In: Linberg, SE, ed. Expediting drug and biologics development: a strategic approach. Watham, Ma.: PAREXEL International, 2006:67-92.

Carron Sher, M.B., Ch.B.

• Rainier S, Sher C, Reish O, Thomas D, Fink JK. De novo occurrence of novel SPG3A/atlastin mutation presenting as cerebral palsy. Arch Neurol 2006;63:445-7.

Dafna Werner, M.Sc.

• Cohen H, Maayan R, Touati-Werner D, Kaplan Z, A Matar M, Loewenthal U, Kozlovsky N, Weizman R. Decreased circulatory levels of neuroactive steroids in behaviourally more extremely affected rats subsequent to exposure to a potentially traumatic experience. Int J Neuropsychopharmacol 2006 May 4;:1-7 [Epub ahead of print]

• Malkesman O, Braw Y, Maayan R, Weizman A, Overstreet DH, Shabat-Simon M, Kesner Y, Touati-Werner D, Yadid G, Weller A. Two different putative genetic animal models of childhood depression. Biol Psychiatry 2006;59:17-23.